iSpecimen CEO Christopher Ianelli and COO Jill Mullan depart; CFO Tracy Curley named interim CEO

iSpecimen Inc.

CEO and President Christopher Ianelli vacated positions on Sept 21, 2022, after non-renewal of employment agreement.
COO Jill Mullan will vacate her role effective Oct 24, 2022, also due to non-renewal.
CFO Tracy Curley appointed interim CEO effective Sept 21, 2022, while remaining CFO.
Both departing executives will continue as employees through Oct 24, 2022, to ensure transition.
Company is negotiating separation agreements; business and balance sheet described as strong.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jill Mullan

Chief Operating Officer

ISPC · iSpecimen Inc.

Effective: 2022-10-24
Filed: September 22, 2022, 7:59 PM ET

On September 20, 2022, the Board received a similar notice of departure from Jill Mullan to vacate the position of Chief Operating Officer of the Company, effective as of October 24, 2022, as a result of the non-renewal of her Executive Employment Agreement dated June 21, 2021.

Departed (interim)

Christopher Ianelli

Chief Executive Officer and President

ISPC · iSpecimen Inc.

Effective: 2022-09-21
Successor: Tracy Curley
Filed: September 22, 2022, 7:59 PM ET

On September 21, 2022, pursuant to the mutual agreement of Dr. Ianelli and the Board, Dr. Ianelli vacated his positions as Chief Executive Officer and President of the Company.

Appointed (interim)

Tracy Curley

Interim Chief Executive Officer

ISPC · iSpecimen Inc.

Effective: 2022-09-21
Filed: September 22, 2022, 7:59 PM ET

The Board appointed Tracy Curley, who currently serves as the Chief Financial Officer and Treasurer of the Company, as Interim Chief Executive Officer of the Company, effective immediately upon Dr. Ianelli’s no longer serving as Chief Executive Officer and President of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jill Mullan departed as Chief Operating Officer at iSpecimen Inc..

Action: vacate
Role: Chief Operating Officer

Exact text from the filing

On September 20, 2022, the Board received a similar notice of departure from Jill Mullan to vacate the position of Chief Operating Officer of the Company, effective as of October 24, 2022, as a result of the non-renewal of her Executive Employment Agreement dated June 21, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Christopher Ianelli departed as Chief Executive Officer and President at iSpecimen Inc..

Action: vacated
Role: Chief Executive Officer and President

Exact text from the filing

On September 21, 2022, pursuant to the mutual agreement of Dr. Ianelli and the Board, Dr. Ianelli vacated his positions as Chief Executive Officer and President of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Tracy Curley was appointed as Interim Chief Executive Officer at iSpecimen Inc..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

The Board appointed Tracy Curley, who currently serves as the Chief Financial Officer and Treasurer of the Company, as Interim Chief Executive Officer of the Company, effective immediately upon Dr. Ianelli’s no longer serving as Chief Executive Officer and President of the Company.

View on SEC.gov

iSpecimen Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-102348

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.